All posts by theradoc

TheraDoc v4.6.1 Hardware and Software Requirements

By | Alerts | No Comments

Download TheraDoc v4.6.1 Hardware and Software Requirements PDF

In preparation for the release of TheraDoc® v4.6.1, we have the following important information to communicate.

Client Workstation Browser Requirements

Supported Browsers

Due to performance related issues, the use of Microsoft Internet Explorer 8 (IE 8) will not be officially supported with TheraDoc v4.6.1; however, IE 9, IE 10 and IE 11 will be supported. Be aware if your facility chooses to continue using IE 8, your facility may experience performance problems:

    • If the same browser session is left open indefinitely. To help avoid this issue, end-users should close and restart their browsers at least once a day.
    • Unusual, long “load” time for a browser page that contains a script; such as a large query or report in the TheraDoc application. When this occurs, the following error message displays:A script on this page is causing Internet Explorer to run slowly. If it continues to run, your computer may become unresponsive. Do you want to abort the script?

To help avoid this issue, Microsoft has released a fix that can be used to change the script timeout value by modifying a registry entry. This fix should be made on each workstation where IE 8 is used to run the TheraDoc application. For more information and instructions, see the following entry on the Microsoft Support Web site:
https://support.microsoft.com/en-us/kb/175500

NOTE: Microsoft has announced that after January 12, 2016 it will provide technical support and security updates for only the most recent version of Internet Explorer (currently IE 11). Microsoft is encouraging all users to upgrade to the most current version to ensure ongoing technical support and security updates.

Browser Setting Requirements
Please be aware of the following browser setting requirements for using TheraDoc v4.6.1:

  • Compatibility mode should not be enabled
  • Zoom should be set to 100%
  • Quirks should not be enabled

TheraDoc Application Hardware and Software Requirements

Disclaimer: The following hardware and software specifications are the minimum acceptable for a baseline TheraDoc application installation. Depending on the facility size, user count, and data volume, additional hardware may be required. Failure to meet or exceed these requirements will invalidate any and all performance expectations and TheraDoc support’s ability to remediate any performance based issues that may arise.

Server Hardware Requirements
Assumptions

  • Recommendations are based on Intel 64-bit architecture.
  • The recommendation below should support 200 named users. If more than 200 named users are going to use the system, additional hardware and third-party software may be required.
  • Disk space requirements for 3 years of storage for a growth rate of 120 MB / BE / year.
  • Disk space requirements assume raw HL7 messages are stored for 12 months
  • Disk space requirements assume vital signs data is being sent hourly
  • Vital signs sent more than 1/hour could negatively impact system performance
  • The STAGE server should be separate environment from the PROD servers.
  • If multiple application/web servers are deployed (>4000BE), the member will have to install and configure a load balancer capable of maintaining persistent (aka sticky) connections.

Virtual Machines

  • TheraDoc support recognizes the benefits of VM environments and that VMs are a good use for STAGE/TEST environments and also potentially for PROD APP servers. The best performing implementations are those that have one or more application servers placed on a VM and the database server placed on its own dedicated hardware.
  • Provisioning of virtual machines is the responsibility of the member. Failure to appropriately provision and monitor virtual machines to comply with the minimum hardware specifications below will invalidate any and all performance expectations and TheraDoc support’s ability to remediate any performance based issues that may arise.
  • TheraDoc support recommends that the PROD environment is run on a dedicated database server. Custom consultation is required for placing the database server in a VM environment.
  • NOTE: Having a PROD server on a VM may increase database licensing costs.

Recommended Requirements

Screen Shot 2015-12-21 at 10.15.09 PM

Screen Shot 2015-12-21 at 10.16.01 PM

Notes:

  • For > 30 concurrent users, additional memory may provide performance benefits
  • Memory allocation (single server setup): DB (1GB), ColdFusion (2GB), JasperReports Server (2GB), TESA/KNET (1GB), OS (2GB)
  • Memory allocation (two server setup): ColdFusion (3GB), JasperReports Server (2GB), TESA/KNET (1.5GB), OS (1.5GB), DB (8GB) on a separate server

Screen Shot 2015-12-21 at 10.17.23 PM

Client Hardware and Software Requirements
Workstation

  • Intel dual core processor or better
  • 4 GB Memory
  • 1024×768 Display Resolution
  • 10/100Mbps network interface
  • Keyboard and Mouse
  • Browsers: IE 9, IE 10, IE 11
  • Windows operating system running a compatible version of IE
  • Software enables exporting data to MS Excel 2010 or greater

Pager

  • Alpha-numeric pager
  • Service provider must support WCTP

v4.6.1 Upgrading Recommendations / Requirements
Windows Server 2003 will not be supported with v4.6.1. Windows Server 2012 R2 is supported with v4.6.1.

If upgrading from Windows Server 2003, it is recommended to install TheraDoc v4.6.1 on Windows Server 2012 R2.

Screen Shot 2015-12-21 at 10.19.16 PM

We appreciate your choice in TheraDoc for clinical surveillance and look forward to the release of this new version. To assist with any questions or concerns surrounding this update, please have your Authorized User reach out to TheraDoc Support at tdoc.support@premierinc.com or 877-TDOC-FIX (877-836-2349).

Premier, Inc. continues growth trajectory with acquisition of Hospira’s TheraDoc

By | News | No Comments

Premier, Inc. (NASDAQ: PINC) has reached a definitive agreement to acquire TheraDoc, a market leading provider of clinical surveillance software, for $117 million in cash, subject to potential purchase price adjustments regarding TheraDoc’s actual working capital, cash and indebtedness at closing. The transaction is expected to close in Premier’s fiscal 2015 first quarter ending September 30, 2014, subject to customary closing conditions.

TheraDoc is a wholly-owned subsidiary of Hospira (NYSE: HSP). Premier’s board of directors unanimously approved the transaction, and applicable antitrust approvals have already been obtained. Based on the trailing twelve months operating earnings provided by TheraDoc, the $117 million represents a purchase price multiple in the 10-11 times range.

Read More

Article in Infection Control and Hospital Epidemiology concludes TheraDoc alerting combined with antimicrobial stewardship intervention has multiple postive effects

By | News | No Comments

The article illustrates how TheraDoc’s active alerting was used in combination with antimicrobial stewardship interventions on patients with gram-negative bacteremia. The study discussed in this article was a quasi-experimental retrospective cohort study conducted at three hospitals within Detroit Medical Center, with a combined 1,100 beds. Data resulting from active alerting of a positive blood culture coupled with stewardship intervention was compiled during 2010–2011 and compared to data from patients who received no formalized stewardship intervention during 2009.

Read More

Hospira’s TheraDoc™ Infection Control Assistant Ranked #1 In Its Category In The Latest “Best In KLAS” Report

By | News | No Comments

LAKE FOREST, Ill., Jan. 23, 2013 – Hospira (NYSE: HSP), the world’s leading provider of injectable drugs and infusion technologies, today announced that its TheraDoc™ Infection Control Assistant™ has been ranked as the top product in the Infection Control & Monitoring software category in the recently released Best in KLAS Awards 2012: Software and Services Report (more information available at www.theradoc.com). The full report is available at www.KLASresearch.com. The rankings are based on data from customer surveys of North American hospital and clinic executives, administrators, physicians, nurses, clinicians, and other directors and managers interacting with healthcare equipment and infrastructure solutions.

TheraDoc Infection Control Assistant scored the highest overall performance rating in KLAS’ Infection Control & Monitoring market segment, demonstrating excellence and leadership in serving customers and meeting their expectations. TheraDoc also received the highest product quality rating in its category, and the highest customer willingness to repurchase the software again (95 percent).[1]

“Hospira is honored that TheraDoc has been recognized for excellence in infection monitoring and surveillance software,” said France Pitera, vice president, Clinical Information Technology, Hospira. “This recognition is very meaningful since it comes as a direct result of feedback from TheraDoc users. This close working relationship with our users is one key reason why 100 percent of the more than 600 hospitals and healthcare facilities nationwide that have acquired TheraDoc still retain the system today.*”

The TheraDoc clinical surveillance system helps infection preventionists tackle many of their most significant challenges, including time spent on regulatory reporting, time to identification of healthcare-associated infections (HAIs), time to isolation of patients with infectious diseases, and tracking of organism resistance.

“After a thorough review of available systems, we chose TheraDoc to support our Infection Prevention program,” says Peggy Thompson, R.N., B.S.N., C.I.C., director of Infection Prevention at Tampa General Hospital. “It has proven to be an invaluable tool in the ever-changing world of infections and regulatory requirements. TheraDoc staff is receptive and incorporates changes based on feedback from their customers.”

The TheraDoc Infection Control Assistant provides infection preventionists with real-time (a matter of seconds) information needed to make a valid identification of infections, while leaving final determination in the hands of infection preventionists. The Infection Control Assistant also delivers powerful tools enabling infection preventionists to configure workflow to their unique needs, develop their own alerts, select from a large library of existing alerts, and automate creation of reports for the National Healthcare Safety Network.

As part of a suite of knowledge modules that make critical patient information and medical knowledge readily available, the Infection Control Assistant is designed to help clinicians intervene quickly, prescribe appropriately, and improve the quality and safety of patient care.[2],[3] The TheraDoc Clinical Intelligence™ Platform is the engine that powers these software modules, which also include the Antibiotic Assistant™, ADE Assistant™, Clinical Alerts Assistant™ and Anticoagulation Assistant™. For more information, visit www.theradoc.com.

KLAS is a research firm specializing in monitoring and reporting on the performance of healthcare vendors. KLAS’ mission is to improve delivery by independently measuring vendor performance for the benefit of its healthcare provider partners, consultants, investors, and vendors. Working together with executives from more than 4,500 hospitals and more than 2,500 clinics, KLAS delivers timely reports, trends, and statistics that provide a solid overview of vendor performance in the industry. KLAS measures performance of software, professional services, medical equipment, and infrastructure vendors.

About Hospira

Hospira, Inc., is the world’s leading provider of injectable drugs and infusion technologies. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. The company is headquartered in Lake Forest, Ill., and has approximately 15,000 employees. Learn more at www.hospira.com.

###

Media
Barbara Sullivan

Sullivan & Associates
(714) 374-6174Tareta Adams
Hospira
(224) 212-2535
Financial Community
Karen King

Hospira
(224) 212-2711Ruth Venning
Hospira
(224) 212-2774

[1] “Best in KLAS Awards 2012: Software and Services Report,” December 2012. © 2012 KLAS Enterprises, LLC. All rights reserved. www.KLASresearch.com.

[2] Hellinger W, Alvarez S, Brumble L, Keating M, Mendez J, Darracott R, Young E, Smith R, Mentel J. Optimizing antibiotic therapy with computerized integration of hospital information systems and an antibiotic management team (AMT). Poster session presented at: 42nd Annual Meeting of the Infectious Diseases Society of America; 2004 Sep 30-Oct 3; Boston, MA.

[3] Pass M, Song X, Mackie K, Perl T. Enhanced Isolation Practices To Improve Patient Safety: Preventing Nosocomial Transmission in a Hospital. Am J Infect Control. 2006 June;34(5):E105-E106.